- Report
- April 2025
- 50 Pages
Global
From €2540EUR$2,650USD£2,123GBP
Oxyphenonium bromide is a centrally acting anticholinergic drug used to treat a variety of conditions, including urinary incontinence, irritable bowel syndrome, and motion sickness. It is also used to reduce salivation and sweating in patients with Parkinson's disease. Oxyphenonium bromide is available in tablet, capsule, and syrup forms. It is usually taken orally, but can also be administered intravenously.
Oxyphenonium bromide is a commonly prescribed drug in the central nervous system drug market. It is used to treat a variety of conditions, including urinary incontinence, irritable bowel syndrome, and motion sickness. It is also used to reduce salivation and sweating in patients with Parkinson's disease.
The market for oxyphenonium bromide is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Mylan, Teva Pharmaceuticals, Sun Pharmaceuticals, and Cipla. Show Less Read more